3786 results for «2019»

Filter By

3786 results

Performing BASILICA: a step-by-step guide to prevent coronary obstruction during TAVI

05 Aug 2025

Ahmed Abdelhafez

Author

Ahmed Abdelhafez
Mohamed Abdel-Wahab

Author

Mohamed Abdel-Wahab
Performing BASILICA: a step-by-step guide to prevent coronary obstruction during TAVI

The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation

01 Sep 2025

Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.

Author

Chiara De Biase
The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]

Robocath achieves positive results in R-Evolution multicenter European clinical study on robotic coronary angioplasty

18 May 2022

Fractional flow reserve-guided complete or culprit-only PCI in patients with ST-elevation myocardial Infarction - FULL REVASC

08 Apr 2024

Nicola Ryan provides her take on the FULL REVASC trial which was presented at ACC.24 in Atlanta and published Simultaneously in NEJM.

The FULL REVASC trial is a multicentre registry-based randomised control trial comparing FFR-guided complete revascularisation of non-culprit lesions versus culprit lesion PCI alone in patients presenting...

Nicola Ryan

Author

Nicola Ryan
FFR-guided complete or culprit-only PCI in patients with STEMI

Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial

20 Sep 2022

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...

Nicola Ryan

Author

Nicola Ryan
10-Year Outcomes of Multicenter Randomized Controlled BEST Trial: Everolimus-Eluting Stents or Bypass Surgery for Mutivessel CAD

Sensome announces data from two new studies showing clot-sensing guidewire successfully identifies fresh clot to support decision-making in peripheral artery disease treatment

13 Dec 2024

SWEDEHEART: Improving the quality of cardiology care in Sweden and beyond!

22 May 2025

Lars Wallentin and Stefan James received the Andreas Grüntzig Ethica Award during EuroPCR 2025, on behalf of a wider team of cardiovascular registry experts who have contributed in an extraordinary way to the PCR mission. 

Improving the quality of cardiology care in Sweden and beyond!

A randomised trial comparing imaging-guided PCI with Orsiro vs Xience

18 May 2021

Previous clinical trials suggested that ultra-thin strut biodegradable polymer sirolimus-eluting stent (BP-SES) may be associated with lower target lesion failure (TLF) when compared to durable polymer everolimus-eluting stents (DP-EES). However, the possible underlying mechanisms remain unclear. Therefore, the all-comers CASTLE study was designed to assess the...

Authors :

A randomised trial comparing imaging-guided PCI with Orsiro vs Xience

PCR London Valves 2018 - Editorial from the Vice Chairman and Chairman of PCR

Jean Fajadet and William Wijns share their thoughts on PCR’s flagship learning platform for valvular interventions

IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly

28 Jan 2022

BIOTRONIK Sets New Clinical Benchmark with Ultrathin Strut Orsiro Coronary Drug-Eluting Stent

28 Feb 2022

One-month ticagrelor monotherapy after PCI in acute coronary syndromes: Principal results from the double-blind, placebo-controlled Ultimate DAPT trial

07 Apr 2024

Elad Asher provides his take on the ULTIMATE-DAPT Trial results which Gregg W Stone presented at ACC.24 in Atlanta.

Elad Asher

Author

Elad Asher
One-month ticagrelor monotherapy after PCI in acute coronary syndromes: Principal results from the double-blind, placebo-controlled Ultimate DAPT trial

Robocath performs world’s First-In-Human remote robotic coronary angioplasty between two Chinese cities 1,700 miles apart

14 Dec 2023

Promising Safety and Efficacy Results for Supraflex Cruz in HBR Subset Analysis from FIRE Trial, with 1-Month DAPT

03 Nov 2023

Protein and exercise to reverse frailty in older men and women undergoing transcatheter aortic valve replacement: The PERFORM-TAVR Trial

08 Apr 2024

Panos Xaplanteris provides his take on the results of PERFORM-TAVR presented by Jonathan Afilalo at ACC.24 in Atlanta.

Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris
PERFORM-TAVR: Protein and exercise to reverse frailty in older patients undergoing TAVR

Fire Trial Shows Positive Results, presented at ESC Congress 2023

29 Aug 2023

2026 Andreas Grüntzig Ethica Award presented to Roxana Mehran

20 May 2026

Each year, the Andreas Grüntzig Ethica Award – the highest honour in the interventional cardiology community – is presented to those who have contributed in an extraordinary way to the PCR mission. 

2026 Andreas Grüntzig Ethica Award presented to Roxana Mehran

ViV challenges in degenerated sutureless bioprosthesis

08 Apr 2025

Watch this EuroIntervention image to learn how the collision of a TAV device during valve crossing in ViV TAVI can potentially cause instability or dehiscence of the sutureless bioprosthesis, contributing to severe poorly tolerated PVL.

New challenges during transcatheter aortic valve-in-valve implantation inside a degenerated sutureless bioprosthesis

Complicated subendothelial dissection during left anterior descending coronary artery – first diagonal branch bifurcation treatment with Culotte technique

06 Jan 2025

Learn more about troubleshooting and tailor-made treatment combining 2D and 3D OCT thanks to this image in cardiology!

Troubleshooting of a complicated subendothelial dissection using 2D and 3D OCT

Jupiter Endovascular closes oversubscribed Series B Financing, surpassing $40 million target

07 Oct 2025

Didn’t find what you were looking for?